https://www.selleckchem.com/pr....oducts/heparan-sulfa
6 days (SD 6.4). Studies used lopinavir/ritonavir, hydroxychloroquine plus ritonavir/lopinavir, hydroxychloroquine with and without azithromycin, ribavirin plus interferon and interferon alfa. The proportion of individuals who remained asymptomatic was 91% (463/588 patients; 95%CI 78.3%-98.7%); and asymptomatic individuals discharged with negative PCR was 86% (102/124 individuals; 95%CI 58.4%-100%). There is no standard treatment for asymptomatic COVID-19 individuals. There are no studies of adequate design to make this decision
Like
Comment
Share
